
Zealand Pharma and Roche Partner to Co-Develop Petrelintide for Overweight and Obesity Treatment
Zealand Pharma A/S, a biotechnology company focused on the discovery and development of innovative peptide-based medicines, announces a global collaboration and license agreement with Roche to develop petrelintide, Zealand Pharma’s amylin analog with …